---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-063253"
form_type: "8-K"
ticker: "WHWK"
cik: "0001422142"
company_name: "Whitehawk Therapeutics, Inc."
filed_at: "2025-03-26T23:59:59+00:00"
generated_at: "2026-05-24T04:52:33.335751+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Whitehawk completes sale of Aadi Subsidiary to Kaken for $102.4M cash

## Summary
- Sale of 100% of Aadi Subsidiary, Inc. to KAKEN INVESTMENTS INC. closed on March 25, 2025.
- Cash purchase price of $102.4 million after adjustments paid by Purchaser.
- Pro forma financial information to be filed by amendment within four business days.
- Deal previously announced on December 19, 2024 under Stock Purchase Agreement.

## SEC filing metadata
- accession: 0001193125-25-063253
- form_type: 8-K
- ticker: WHWK
- cik: 0001422142
- company_name: Whitehawk Therapeutics, Inc.
- filed_at: 2025-03-26T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1422142/000119312525063253/0001193125-25-063253-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1422142/000119312525063253/d937606d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-063253
- JSON: https://secwatch.observer/filing/0001193125-25-063253.json
- Plain text: https://secwatch.observer/filing/0001193125-25-063253.txt

## Key facts
- M&A Transactions
  Whitehawk Therapeutics, Inc. completed a disposition involving KAKEN INVESTMENTS INC. for $102.4 million (closed 2025-03-25).
  - Action: disposition
  - Counterparty: KAKEN INVESTMENTS INC.
  - Consideration: $102.4 million
  - Closing: 2025-03-25
  source text: and Aadi Subsidiary, Inc. on December 19, 2024. In accordance with the Purchase Agreement, upon the closing of the Divestiture, Purchaser paid to the Company a cash payment of $102.4 million (following applicable purchase price adjustments under the Purchase Agreement). The foregoing description of the Divestiture and the Purchase Agreement does not purport to be
  evidence_url: https://www.sec.gov/Archives/edgar/data/1422142/000119312525063253/0001193125-25-063253-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.